trapped gas glp 1 Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? Potential Use of GLP-1 and

But despite rising rates of diabetes and obesity, access to these medicines remain limited in South Africa, writes Catherine Tomlinson for Spotlight, who finds out which of the GLP-1 agonists are []

In the months since we launched the GLP-1 Supply Tracker, theres been news and updates about the GLP-1 shortages

The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.

The databases used in this study are accessible to other researchers by contacting the data providers and acquiring data use agreements or licenses.

Although use of glucagon-like peptide-1 agonists for diabetes and weight loss has soared with indications now expanding into liver diseases, specifically metabolic dysfunction-associated steatohepatitis, the jury is still out on its benefit.With the recent FDA approval of Rezdiffra (resmetirom, Madrigal Pharmaceuticals) for the treatment for MASH, the question is whether (and how) GLP-1s will fit